Premium reports Regulatory report: US states that sell intoxicating hemp-derived cannabinoids through dispensaries
0

Regulatory report: US states that sell intoxicating hemp-derived cannabinoids through dispensaries

Published: 16th August 2022 | No. pages: 26
$995.00

Description

Dispensaries are an important retail channel for cannabis in the US, as customers are generally there to solely purchase cannabis products. They are also important because they are the only places that can legally sell cannabis under individual state law. However, some states have a requirement that only allows the sale of heavily tested cannabis products, requirements that other hemp products would not meet. This report looks at which states allow the sale of intoxicating hemp-derived cannabinoids (IHDCs) in dispensaries.

Reasons to buy

Intoxication hemp-derived cannabinoids (IHDCs) have been major disruptors in the CBD and legal cannabis sectors in the US for some time now, with a number of states deciding to regulate their sale rather than banning them. If you are interested in IHDCs and their status in the US, then this report offers invaluable information about which states allow their sale in cannabis dispensaries. It also looks at which states have dispensaries offering them, regardless of whether they are permitted.

Table of contents

  1. Executive summary
  2. Introduction
  3. Availability of IHDCs in dispensaries
  4. State-by-state regulation
  5. Alabama
  6. Alaska
  7. Arizona
  8. Arkansas
  9. California
  10. Colorado
  11. Connecticut
  12. Delaware
  13. Florida
  14. Hawaii
  15. Illinois
  16. Iowa
  17. Louisiana
  18. Maine
  19. Maryland
  20. Massachusetts
  21. Michigan
  22. Minnesota
  23. Mississippi
  24. Missouri
  25. Montana
  26. Nevada
  27. New Hampshire
  28. New Jersey
  29. New Mexico
  30. New York
  31. North Dakota
  32. Ohio
  33. Oklahoma
  34. Oregon
  35. Pennsylvania
  36. Rhode Island
  37. South Dakota
  38. Utah
  39. Vermont
  40. Virginia
  41. Washington
  42. West Virginia

Methodology

The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including online and offline resources and data, specialist legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground professionals.

Latest reports

Description

Dispensaries are an important retail channel for cannabis in the US, as customers are generally there to solely purchase cannabis products. They are also important because they are the only places that can legally sell cannabis under individual state law. However, some states have a requirement that only allows the sale of heavily tested cannabis products, requirements that other hemp products would not meet. This report looks at which states allow the sale of intoxicating hemp-derived cannabinoids (IHDCs) in dispensaries.

Get a free sample of this premium report:

“ Regulatory report: US states that sell intoxicating hemp-derived cannabinoids through dispensaries ”

[contact-form-7 404 "Not Found"]

-

“ Regulatory report: US states that sell intoxicating hemp-derived cannabinoids through dispensaries ”

[contact-form-7 404 "Not Found"]